Filing metadata

Accession number
0001209191-22-055289
Form type
Form 3
Filer
Anebulo Pharmaceuticals, Inc.
CIK
CIK 1815974
Filed
Nov 02, 2022
Reporting period
Oct 28, 2022
Description
Initial ownership

Explore SEC Filings Hub